Drug Safety


Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/leo-pharma-and-hitgen-enter-research-collaboration/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26

Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/drug-development-deal-signed-by-soin-neuroscience-for-non-addicting-pain-killer/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26

Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/orphan-drug-designation-granted-by-fda-to-omeros-oms721-for-treatment-of-iga-nephropathy/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26
share

AstraZeneca announced that it has entered into an agreement with Aspen Global Incorporated under which AGI will now...

share

Champions Oncology, a company engaged in the development and sale of advanced technology solutions and products to personalize...

share

Teva Pharmaceutical Industries announced the launch of generic Axiron®1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the...

share

A new consortium, led by Oxford BioMedica, will take part in a two-year, £2m project focused on gene...

share

Biognosys announced that it has secured USD 5m funding from new and existing investors in an extended series C...

share

HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with LEO Pharma A/S ,...

share

Soin Neuroscience, a biotech startup based in Dayton, OH, has recently signed a drug development deal with Cleveland...

share

Omeros Corporation announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment...